Xellia Pharmaceuticals

xellia pharmaceuticals is a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. our anti-infective treatments are generics that combat serious bacterial and antibiotic resistant infections as well as certain fungal diseases. we are a world leader in the development, manufacturing and supply of fermented anti-infectives sold as active pharmaceutical ingredients and finished dosage forms to key pharmaceutical industry companies. headquartered in copenhagen, denmark and owned by novo a/s, xellia pharmaceuticals has more than 1200 employees globally. from state-of-the-art manufacturing sites in the u.s., china, denmark and hungary to r&d sites in norway and croatia; xellia pharmaceuticals excels within innovative product development to deliver high quality products to its customers. our product portfolio of anti-bacterial and anti-fungal products used for the treatment of severe infections, inc